Tennessee Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 21 (72% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 6,972
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 18.52%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 1,030
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 24.70%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 80.67% 72.23%
White, Hispanic/Latino Patients 2.21% 3.40%
Black/African American, Non-Hispanic/Latino Patients 11.80% 15.92%
Black/African American, Hispanic/Latino Patients 0.04% 0.00%
Asian Patients3 0.27% 0.10%
American Indian/Alaska Native Patients3 0.11% 0.10%
Native Hawaiian/Other Pacific Islander Patients3 0.16% 0.58%
Patients with More than one race3 0.72% 0.68%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 3.01% 2.91%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.63% 0.68%
Unreported/Refused to Report Race and Ethnicity 0.37% 3.40%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 402
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 48.60%
COVID-19 Immunization Series Completed 1,006
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 33.37%
COVID-19 Immunization Series Additional 138
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 41.18%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 50.25% 65.90% 57.97%
White, Hispanic/Latino Patients 7.46% 9.15% 3.62%
Black/African American, Non-Hispanic/Latino Patients 25.12% 14.91% 18.12%
Black/African American, Hispanic/Latino Patients 0.00% 0.10% 0.00%
Asian Patients3 0.75% 0.50% 1.45%
American Indian/Alaska Native Patients3 0.00% 0.20% 17.39%
Native Hawaiian/Other Pacific Islander Patients3 0.25% 0.30% 0.00%
Patients with More than one race3 5.22% 0.50% 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 8.71% 7.36% 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.00% 0.70% 0.00%
Unreported/Refused to Report Race and Ethnicity 1.24% 0.40% 1.45%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 42.86%
1 to 24 Hours 23.81%
More Than 24 Hours 33.33%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 19.05%
Vaccine confidence 42.86%
Vaccine storage capacity 4.76%
Vaccine supply 0.00%
Other 0.00%
None 47.62%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 9.52%
Average Percent of Health Center Visits Conducted Virtually 9.76%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 28.57%
Number of Mobile Van Sites 7
Number of Pop-up Clinics 13
Number of School-Based Vaccination Sites 0

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 14.29%
Refer patients to another organization that provides monoclonal antibody therapies 52.38%
None 38.10%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 9.52%
Patient awareness/education 0.00%
Staffing capacity 14.29%
Therapy administration/onsite logistics 14.29%
Other 9.52%
None 61.90%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021